Masayuki Kanai

1.8k total citations
21 papers, 1.5k citations indexed

About

Masayuki Kanai is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Masayuki Kanai has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Masayuki Kanai's work include DNA Repair Mechanisms (6 papers), Cancer-related Molecular Pathways (6 papers) and PARP inhibition in cancer therapy (6 papers). Masayuki Kanai is often cited by papers focused on DNA Repair Mechanisms (6 papers), Cancer-related Molecular Pathways (6 papers) and PARP inhibition in cancer therapy (6 papers). Masayuki Kanai collaborates with scholars based in Japan, United States and Germany. Masayuki Kanai's co-authors include Masanao Miwa, Kenji Fukasawa, Shuji Hanai, Emily H. Cheng, Song‐Hee Kim, Eiji Sugihara, Kazuhiko Hanashiro, A. Hamid Boulares, Bhavneet Bhinder and Hitoshi Takahashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Masayuki Kanai

21 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayuki Kanai Japan 17 1.0k 619 268 215 175 21 1.5k
Emma Bolderson Australia 25 1.9k 1.9× 844 1.4× 383 1.4× 149 0.7× 134 0.8× 60 2.4k
David Karnak United States 19 1.2k 1.1× 565 0.9× 173 0.6× 108 0.5× 384 2.2× 29 1.6k
Farjana Fattah United States 20 959 0.9× 697 1.1× 175 0.7× 187 0.9× 46 0.3× 40 1.6k
Ralph Imhof Switzerland 23 2.0k 2.0× 1.3k 2.0× 211 0.8× 433 2.0× 96 0.5× 27 2.7k
Ashutosh Mishra United States 19 888 0.9× 133 0.2× 150 0.6× 242 1.1× 170 1.0× 40 1.3k
Constanze Wiek Germany 26 1.0k 1.0× 512 0.8× 244 0.9× 325 1.5× 103 0.6× 62 1.7k
Anne Quillet‐Mary France 23 943 0.9× 407 0.7× 159 0.6× 735 3.4× 106 0.6× 54 1.9k
Vrushank Davé United States 22 1.1k 1.1× 266 0.4× 191 0.7× 127 0.6× 112 0.6× 33 1.7k
Lang Ngo United States 17 2.2k 2.2× 705 1.1× 101 0.4× 127 0.6× 63 0.4× 19 2.5k
Farrell MacKenzie Canada 20 1.4k 1.4× 263 0.4× 94 0.4× 117 0.5× 194 1.1× 20 1.9k

Countries citing papers authored by Masayuki Kanai

Since Specialization
Citations

This map shows the geographic impact of Masayuki Kanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Kanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Kanai more than expected).

Fields of papers citing papers by Masayuki Kanai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Kanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Kanai. The network helps show where Masayuki Kanai may publish in the future.

Co-authorship network of co-authors of Masayuki Kanai

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Kanai. A scholar is included among the top collaborators of Masayuki Kanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Kanai. Masayuki Kanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raghav, Kanwal, Takayuki Yoshino, Hiroya Taniguchi, et al.. (2021). An open-label, phase II study of patritumab deruxtecan (HER3-DXd, U3-1402) in patients (pts) with previously treated advanced/metastatic colorectal cancer (CRC).. Journal of Clinical Oncology. 39(3_suppl). TPS157–TPS157. 4 indexed citations
2.
Zhu, Andrew X., David Chen, Masayuki Kanai, et al.. (2016). Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma. Journal of Hepatology. 65(2). 296–304. 24 indexed citations
3.
Chen, Hui‐Chen, Masayuki Kanai, Akane Inoue‐Yamauchi, et al.. (2015). An interconnected hierarchical model of cell death regulation by the BCL-2 family. Nature Cell Biology. 17(10). 1270–1281. 205 indexed citations
4.
Zhang, Ji, Jing Fan, Sriram Venneti, et al.. (2014). Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion. Molecular Cell. 56(2). 205–218. 341 indexed citations
5.
Kanai, Masayuki, Wei‐Min Tong, Zhao‐Qi Wang, & Masanao Miwa. (2007). Haploinsufficiency of poly(ADP-ribose) polymerase-1-mediated poly(ADP-ribosyl)ation for centrosome duplication. Biochemical and Biophysical Research Communications. 359(3). 426–430. 16 indexed citations
6.
Kanai, Masayuki, Kazuhiko Hanashiro, Song‐Hee Kim, et al.. (2007). Inhibition of Crm1–p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation. Nature Cell Biology. 9(10). 1175–1183. 168 indexed citations
7.
Kanai, Masayuki, Zhiyong Ma, Hideki Izumi, et al.. (2007). Physical and functional interaction between mortalin and Mps1 kinase. Genes to Cells. 12(6). 797–810. 43 indexed citations
8.
Nitta, Takayuki, Masayuki Kanai, Eiji Sugihara, et al.. (2006). Centrosome amplification in adult T‐cell leukemia and human T‐cell leukemia virus type 1 Tax‐induced human T cells. Cancer Science. 97(9). 836–841. 28 indexed citations
9.
Ma, Zhiyong, Masayuki Kanai, Kenji Kawamura, et al.. (2006). Interaction between ROCK II and Nucleophosmin/B23 in the Regulation of Centrosome Duplication. Molecular and Cellular Biology. 26(23). 9016–9034. 77 indexed citations
10.
Sugihara, Eiji, Masayuki Kanai, Takayuki Nitta, et al.. (2006). Suppression of Centrosome Amplification after DNA Damage Depends on p27 Accumulation. Cancer Research. 66(8). 4020–4029. 36 indexed citations
11.
Kanai, Masayuki, et al.. (2003). Subcellular localization of poly(ADP-ribose) glycohydrolase in mammalian cells. Biochemical and Biophysical Research Communications. 307(4). 915–921. 52 indexed citations
12.
Sugihara, Eiji, Masayuki Kanai, Akira Matsui, et al.. (2003). Enhanced expression of MYCN leads to centrosome hyperamplification after DNA damage in neuroblastoma cells. Oncogene. 23(4). 1005–1009. 14 indexed citations
13.
Kanai, Masayuki, Wei‐Min Tong, Eiji Sugihara, et al.. (2003). Involvement of Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribosyl)ation in Regulation of Centrosome Function. Molecular and Cellular Biology. 23(7). 2451–2462. 111 indexed citations
14.
Hanai, Shuji, Masayuki Kanai, Keiji Okamoto, et al.. (2003). Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proceedings of the National Academy of Sciences. 101(1). 82–86. 161 indexed citations
15.
Kanai, Masayuki, et al.. (2002). [Met5]enkephalin-Arg-Gly-Leu-induced antinociception is greatly increased by peptidase inhibitors. European Journal of Pharmacology. 453(1). 53–58. 11 indexed citations
16.
Yamashita, Kenichi, Masayuki Kanai, Kazuhiko Uchida, et al.. (2002). Electrochemical analysis of single nucleotide polymorphisms of p53 gene. Talanta. 56(5). 829–835. 33 indexed citations
17.
Kanai, Masayuki, Masahiro Uchida, Shuji Hanai, et al.. (2000). Poly(ADP-ribose) Polymerase Localizes to the Centrosomes and Chromosomes. Biochemical and Biophysical Research Communications. 278(2). 385–389. 59 indexed citations
18.
Yoshikawa, Masanobu, Ken Kitamura, Tomomi Kobayashi, et al.. (1999). Time Course of Changes in .MU.-Opioid Receptor mRNA Levels in the Periaqueductal Gray of Rat Brain by a Single or Repeated Injections of Antisense Oligodeoxynucleotides.. The Japanese Journal of Pharmacology. 81(2). 209–215. 3 indexed citations
19.
Hiranuma, Toyokazu, K Kitamura, Takao Taniguchi, et al.. (1998). Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides. Naunyn-Schmiedeberg s Archives of Pharmacology. 357(3). 276–282. 25 indexed citations
20.
Hiranuma, Toyokazu, et al.. (1998). Protection against Dynorphin-(1–8) Hydrolysis in Membrane Preparations by the Combination of Amastatin, Captopril and Phosphoramidon. Journal of Pharmacology and Experimental Therapeutics. 286(2). 863–869. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emma Bolderson Breakdown of academic impact, for papers by David Karnak Breakdown of academic impact, for papers by Farjana Fattah Breakdown of academic impact, for papers by Ralph Imhof Breakdown of academic impact, for papers by Ashutosh Mishra Breakdown of academic impact, for papers by Constanze Wiek Breakdown of academic impact, for papers by Anne Quillet‐Mary Breakdown of academic impact, for papers by Vrushank Davé Breakdown of academic impact, for papers by Lang Ngo Breakdown of academic impact, for papers by Farrell MacKenzie
Rankless by CCL
2026